Bristol-Myers Squibb
Most Read
A key trial for a Bristol-Myers cancer drug fails in a ‘major surprise’
Pharmalot, Pharmalittle: Bristol-Myers cancer drug misses main goal in late-stage study
Up and down the ladder: The latest comings and goings
Bristol-Myers pays $30 million to settle kickback charges
Pharmalot, Pharmalittle: Carl Icahn takes a stake in Allergan
Pharmalot, Pharmalittle: UK refuses to cover Bristol lung cancer drug
